Windsor Biogen Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 7.15 M
- Company Age 27 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 Cr
- Revenue Growth -99.97%
- Profit Growth 41.23%
- Ebitda 42.50%
- Net Worth -8.36%
- Total Assets -0.38%
About Windsor Biogen
Windsor Biogen Private Limited (WBPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 April 1997 and has a history of 27 years and nine months. Its registered office is in Howrah, West Bengal, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 7.15 M.
The company currently has active open charges totaling ₹5.00 Cr.
Milan Mondal and Suresh Pandey serve as directors at the Company.
Company Details
-
Location
Howrah, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51109WB1997PTC083909
-
Company No.
083909
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Apr 1997
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Windsor Biogen?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Milan Mondal
|
Additional Director | 10-Aug-2022 | Current |
|
Suresh Pandey
|
Additional Director | 15-Dec-2020 | Current |
Financial Performance of Windsor Biogen.
Windsor Biogen Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.97% decrease. The company also saw a substantial improvement in profitability, with a 41.23% increase in profit. The company's net worth dipped by a decrease of 8.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Windsor Biogen?
Unlock access to Windsor Biogen's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Adept Green Agro Industries LimitedMilan Mondal is a mutual person
-
Exemplar Dealcom Private Limited
Milan Mondal is a mutual person
-
Ridhaan Nirman Private Limited
Suresh Pandey is a mutual person
Charges (Loans)
₹5.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 5.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Mar 2020 | Others | ₹5.00 Cr | Open |
How Many Employees Work at Windsor Biogen?
Unlock and access historical data on people associated with Windsor Biogen, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Windsor Biogen, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Windsor Biogen's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
